KLINGENSTEIN FIELDS & CO LP - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,122 filers reported holding NOVARTIS A G in Q1 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.2%.

Quarter-by-quarter ownership
KLINGENSTEIN FIELDS & CO LP ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$839,632
+0.9%
8,2430.0%0.04%
+7.9%
Q2 2023$831,801
+9.7%
8,2430.0%0.04%0.0%
Q1 2023$758,356
-9.4%
8,243
-10.7%
0.04%
-11.6%
Q4 2022$837,164
+19.3%
9,228
-0.2%
0.04%
+10.3%
Q3 2022$702,000
-10.1%
9,2420.0%0.04%
-4.9%
Q2 2022$781,000
+7.7%
9,242
+11.9%
0.04%
+32.3%
Q1 2022$725,000
-12.5%
8,257
-12.9%
0.03%
-6.1%
Q4 2021$829,000
+3.8%
9,479
-3.0%
0.03%
-2.9%
Q3 2021$799,000
-0.2%
9,770
+11.3%
0.03%
+3.0%
Q2 2021$801,000
+5.3%
8,782
-1.3%
0.03%
-2.9%
Q1 2021$761,000
-9.5%
8,9020.0%0.03%
-10.5%
Q4 2020$841,000
+11.1%
8,902
+2.3%
0.04%0.0%
Q3 2020$757,000
-0.4%
8,7020.0%0.04%
-9.5%
Q2 2020$760,000
+6.0%
8,7020.0%0.04%
-10.6%
Q1 2020$717,000
-13.0%
8,7020.0%0.05%
+14.6%
Q4 2019$824,000
+8.3%
8,702
-0.6%
0.04%
+2.5%
Q3 2019$761,000
-15.9%
8,758
-11.6%
0.04%
-14.9%
Q2 2019$905,000
-5.6%
9,908
-0.7%
0.05%
-9.6%
Q1 2019$959,000
+11.8%
9,974
-0.2%
0.05%
+44.4%
Q4 2018$858,000
-0.3%
9,9940.0%0.04%
+16.1%
Q3 2018$861,000
+8.6%
9,994
-4.8%
0.03%
+3.3%
Q2 2018$793,000
-14.8%
10,494
-8.8%
0.03%
-16.7%
Q1 2018$931,000
-3.6%
11,5090.0%0.04%0.0%
Q4 2017$966,000
-7.1%
11,509
-5.0%
0.04%
-10.0%
Q3 2017$1,040,000
-56.6%
12,109
-57.8%
0.04%
-57.4%
Q2 2017$2,397,000
+12.3%
28,718
-0.1%
0.09%
+8.0%
Q1 2017$2,134,000
+1.4%
28,737
-0.5%
0.09%
-5.4%
Q4 2016$2,104,000
+74.3%
28,880
+89.0%
0.09%
+64.3%
Q3 2016$1,207,000
-4.3%
15,2800.0%0.06%
-5.1%
Q2 2016$1,261,000
+41.7%
15,280
+24.4%
0.06%
+31.1%
Q1 2016$890,000
-25.6%
12,280
-11.7%
0.04%
-23.7%
Q4 2015$1,197,000
-6.1%
13,909
+0.2%
0.06%
-6.3%
Q3 2015$1,275,000
-6.5%
13,8750.0%0.06%
+3.3%
Q2 2015$1,364,000
-0.3%
13,8750.0%0.06%0.0%
Q1 2015$1,368,000
+6.1%
13,875
-0.2%
0.06%
+7.0%
Q4 2014$1,289,000
-46.6%
13,908
-45.8%
0.06%
-45.7%
Q3 2014$2,415,000
+0.1%
25,655
-3.8%
0.10%
+1.9%
Q2 2014$2,413,000
+6.5%
26,6550.0%0.10%
+1.0%
Q1 2014$2,266,000
-45.2%
26,655
-48.1%
0.10%
-31.1%
Q4 2013$4,132,000
-1.3%
51,403
-5.8%
0.15%
-9.8%
Q3 2013$4,185,000
-7.3%
54,553
-14.6%
0.16%
+1.2%
Q2 2013$4,515,00063,8470.16%
Other shareholders
NOVARTIS A G shareholders Q1 2022
NameSharesValueWeighting ↓
NEXTHERA CAPITAL LP 198,000$14,422,0008.45%
PRENTISS SMITH & CO INC 133,202$9,702,0005.92%
EXENCIAL WEALTH ADVISORS, LLC 178,313$12,988,0005.50%
MANAGED ASSET PORTFOLIOS, LLC 185,868$13,538,0005.33%
Osher Van de Voorde Investment Management 114,735$8,357,0004.59%
BROWN BROTHERS HARRIMAN & CO 10,971,272$799,147,0004.37%
PROFESSIONAL ADVISORY SERVICES INC 238,542$17,375,0004.04%
Elefante Mark B 4,579$333,0004.02%
COMPASS CAPITAL MANAGEMENT, INC 271,536$19,779,0003.69%
CGOV Asset Management 972,731$95,135,0003.51%
View complete list of NOVARTIS A G shareholders